Cytosorbents announces inducement grants under nasdaq listing rule 5635(c)(4)

Princeton, n.j., aug. 16, 2024 (globe newswire) -- cytosorbents corporation (nasdaq: ctso), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today announced that it granted inducement equity awards on august 14, 2024 (the “grant date”) to its newly-hired chief financial officer, peter j. mariani.
NDAQ Ratings Summary
NDAQ Quant Ranking